Experimental data that are presented show that the multifunctional multicolor nanoprobe can be used for the highly selective and simultaneous capture of targeted TNBC and HER-2(+) or ER(+) breast cancer cells, and the capture efficiency can be as high as 98%. This evidence concerns the gene ESR1 and breast carcinoma.